INGN - Inogen Inc
IEX Last Trade
12.27
-0.480 -3.912%
Share volume: 109,627
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$12.75
-0.48
-3.77%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-03 | 2023-02-24 | 2023-05-05 | 2023-08-08 | 2023-11-09 | 2024-03-01 | 2024-05-08 | |
| Assets | |||||||||
| Total Assets | 470.069 M | 469.584 M | 405.041 M | 385.674 M | 374.351 M | 343.696 M | 326.194 M | 315.599 M | |
| Current Assets | 315.447 M | 317.776 M | 304.645 M | 283.147 M | 269.223 M | 225.268 M | 207.067 M | 199.194 M | |
| Inventories | 33.496 M | 35.725 M | 34.093 M | 38.822 M | 30.744 M | 24.015 M | 21.840 M | 24.601 M | |
| Other Current Assets | 25.514 M | 20.306 M | 19.187 M | 14.016 M | 15.377 M | 14.363 M | 13.846 M | 13.589 M | |
| Short Term Investments | 25.514 M | 20.306 M | 19.187 M | 14.016 M | 15.377 M | 14.363 M | 13.846 M | 13.589 M | |
| Total Receivables | 32.816 M | 52.112 M | 64.351 M | 55.744 M | 52.956 M | 48.850 M | 42.910 M | 41.199 M | |
| Current Cash | 223.621 M | 209.633 M | 187.014 M | 174.565 M | 170.146 M | 138.040 M | 128.471 M | 119.805 M | |
| Total Non-current Assets | 154.622 M | 151.808 M | 100.396 M | 102.527 M | 105.128 M | 118.428 M | 119.127 M | 116.405 M | |
| Property Plant Equipment | 40.418 M | 40.632 M | 43.269 M | 45.942 M | 49.195 M | 49.525 M | 50.316 M | 49.270 M | |
| Other Assets | 2.067 M | 2.323 M | 2.445 M | 2.590 M | 2.777 M | 3.783 M | 3.825 M | 3.819 M | |
| Intangible Assets | 55.850 M | 53.700 M | 177.000 K | 0.000 | 0.000 | 34.067 M | 34.591 M | 32.907 M | |
| Goodwill | 32.803 M | 32.674 M | 32.852 M | 32.887 M | 32.889 M | 9.869 M | 10.057 M | 9.834 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 470.069 M | 469.584 M | 405.041 M | 385.674 M | 374.351 M | 343.696 M | 326.194 M | 315.599 M | |
| Total liabilities | 113.532 M | 118.742 M | 107.635 M | 104.377 M | 99.572 M | 113.066 M | 121.382 M | 123.701 M | |
| Total current liabilities | 59.340 M | 65.736 M | 65.349 M | 63.379 M | 59.367 M | 60.382 M | 72.496 M | 73.910 M | |
| Accounts Payable | 11.906 M | 21.470 M | 18.237 M | 18.043 M | 13.389 M | 15.408 M | 13.454 M | 15.922 M | |
| Other liabilities | 32.514 M | 32.344 M | 22.522 M | 21.819 M | 21.948 M | 25.390 M | 22.077 M | 23.048 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 32.514 M | 32.344 M | 22.522 M | 21.819 M | 21.948 M | 25.390 M | 22.077 M | 23.048 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 356.537 M | 350.842 M | 297.406 M | 281.297 M | 274.779 M | 230.630 M | 204.812 M | 191.898 M | |
| Common stock | 22.845 M | 22.882 M | 22.928 M | 23.010 M | 23.146 M | 23.231 M | 23.317 M | 23.402 M | |
| Retained earnings | 51.616 M | 42.110 M | -14.500 M | -34.849 M | -44.675 M | -90.394 M | -116.949 M | -131.527 M |